Influenza Diagnostics Market to Reach USD 1.89 Billion by 2030 with a Strong 8% CAGR
The Influenza Diagnostics Market size was valued at USD 1.1 Billion in 2023 and the total Influenza Diagnostics revenue is expected to grow at a CAGR of 8 % from 2024 to 2030, reaching nearly USD 1.89 Billion in 2030.
Rapid antigen tests detect viral proteins in respiratory specimens, providing quick results within minutes. They are less sensitive than molecular assays but offer rapid point-of-care testing Viral culture involves inoculating respiratory specimens onto cell cultures to isolate and identify influenza viruses. It allows for strain characterization and antiviral susceptibility testing The segments covered in the Influenza Diagnostics market report are Test, Technology, and End User.
Download Full PDF Sample Copy of Reseach Report : https://www.maximizemarketresearch.com/request-sample/227991/
Influenza Diagnostics Market Report Scope and Research Methodology
The aim of this report is to provide stakeholders in the Influenza Diagnostics Market with a comprehensive analysis of the industry's current and past state, as well as a projected market size and trends in a clear and concise language. The Influenza Diagnostics Market report covers all essential aspects of the market, including an in-depth examination of key players, such as market leaders, followers, and new entrants. The Influenza Diagnostics Market report features a PORTER and PESTEL analysis, taking into account micro-economic factors that may have an impact on the industry.
Influenza Diagnostics Market Regional Insights
Regional analysis is conducted to assess the status of the Influenza Diagnostics market in countries belonging to North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. The Influenza Diagnostics market is segmented broadly into these regions, allowing for a detailed understanding of the market landscape and dynamics in each geographical area.
Get Free Access to Demo Report, Excel Pivot and ToC : https://www.maximizemarketresearch.com/market-report/influenza-diagnostics-market/227991/
Influenza Diagnostics Market Segmentation
By Test, The Molecular Diagnostics segment accounts for an estimated 25% of the overall Influenza Diagnostics Market. PCR provides unprecedented precision in detecting influenza viruses, even new strains, hence improving patient management and public health surveillance through more trustworthy data. A timely and correct diagnosis allows for early therapeutic efforts, potentially lowering disease severity and spread.
by Test
Rapid Antigen Tests
Molecular Assays (PCR)
Viral Culture
Next-Generation Sequencing (NGS)
Biosensors and Microarrays
Immunofluorescence Assays
by Technology
Molecular Diagnostics
Immunodiagnostics
Next-Generation Sequencing
Traditional Methods
Get Discount On The Purchase Of This Report :https://www.maximizemarketresearch.com/request-sample/227991/
Influenza Diagnostics Market Key Players
1. Becton
2. Abbott Laboratories
3. F. Hoffmann-La Roche AG
4. Quidel Corporation
5. Hologic
6. Thermo Fisher Scientific
7. Altona Diagnostics GmbH
8. Danaher Corporation (US)
9. DiaSorin SpA (Italy)
10. Hologic Inc. (US)
11. Luminex Corporation (US)
12. Meridian Bioscience Inc. (US)
13. Sekisui Diagnostics (US)
14. bioMérieux
15. Siemens Healthineers
Key questions answered in the Influenza Diagnostics Market are:
What is Influenza Diagnostics ?
What was the Influenza Diagnostics market size in 2023?
What is the growth rate of the Influenza Diagnostics Market?
Who are the leading companies and what are their portfolios in Influenza Diagnostics Market?
What segments are covered in the Influenza Diagnostics Market?
Who are the key players in the Influenza Diagnostics market?
Key Offerings:
Past Pricing and price curve by region
Market Size, Share, Size & Forecast by Different Segment | 2024−2030
PESTLE Analysis
PORTER’s analysis
Value chain and supply chain analysis
Legal Aspects of Business by Region
Lucrative business opportunities with SWOT analysis
Recommendations
About Maximize Market Research:
Maximize Market Research is a dynamic market research and consulting firm, staffed by experts from a wide range of industries. Our areas of expertise span across sectors such as medical devices, pharmaceuticals, science and engineering, electronics, industrial machinery, technology, automotive, chemicals, consumer goods, beverages, personal care, and automation. Among the services we offer are industry-validated market forecasts, analysis of emerging technological trends, essential market insights, strategic consulting, competitive landscape evaluations, production and demand assessments, as well as client impact analysis, to name a few.